Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 128 results found. Search for [ russian covid-19 vaccine ]

Results 1 to 21 of 128
BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Chebrolu's invention is based on in-silico methodology. In this, a lead molecule selectively binds with spike protein of COVID-19. She is now planning to work with scientists who are working tirelessly to find vaccine against COVID-19


BusinessToday.In
New Delhi, October 19, 2020
Retail cheque payments fall to 2.96% in FY20 amid digitisation push: RBI; Develop COVID vaccine delivery system akin to polls, disaster management: PM Modi; Digital media, news agencies given a year to comply with 26% FDI cap. Watch this and more news on News Blast.Also Read: Gold price trades flat for second day; silver rates at Rs 61,500


Rashi Bisaria
New Delhi, October 19, 2020
Reliance Jio plans to sells 5G smartphones at Rs 2,500-3,000Reliance Jio is planning to launch a 5G smartphone for less than Rs 5,000 and gradually reduce the price to Rs 2,500-3,000 a unit when it scales up the operation, according to a company official. The company will target 20-30 crore mobile phone users who use 2G connection at present.Coronavirus impact: Passenger vehicle exports dip 57.52% in Apr-SepPassenger vehicle exports bore the brunt of the pandemic in April-September period....


Joe C Mathew
October 18, 2020
Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the coming months


BusinessToday.In
October 18, 2020
Coronavirus vaccine: Meanwhile, the Drug Control General of India (DCGI) on Saturday approved Dr Reddy's proposal to conduct clinical trials for Sputnik V in India


Reuters
October 16, 2020
The company said last month a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


Associated Press
October 15, 2020
We now need to increase production of the first vaccine and the second vaccine, Russian President Vladimir Putin said, adding that the priority was to supply the Russian market with the vaccines


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


BusinessToday.In
October 9, 2020
Coronavirus update: The new rapid COVID-19 testing kit will give test results in less than a minute by simply requiring an individual to blow into a tube, the Israeli envoy to India said


BusinessToday.In
October 9, 2020
Russian Health Minister Mikhail Murashko had said earlier that he expects to approve a Russian coronavirus vaccine developed by the Vector institute in mid-October


BusinessToday.In
October 8, 2020
Twitter was the first company to allow its employees to work from home permanently. The company, however, did not specify which roles will qualify for work-from-home. Twitter employs more than 4,000 people across its global offices


BusinessToday.In
October 8, 2020
Coronavirus vaccine update: The CDSCO panel said that safety and immunogenicity data from early-stage trials of the Russian vaccine Sputnik V that were conducted overseas had a small number of participants


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Reuters
September 29, 2020
Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine said that the pace of its development was necessary under the \"wartime\" conditions of a pandemic but no corners were being cut


Reuters
September 23, 2020
Leaders of the world's two largest economies laid out their competing visions as relations have plunged to their worst level in decades against the backdrop of COVID-19 pandemic


BusinessToday.In
September 22, 2020
Coronavirus vaccine: Russian officials said there is a strong demand for the Sputnik V vaccine from the developing countries. At present, Russia is conducting a clinical trial of the vaccine in Brazil, UAE, Belarus, and Egypt


BusinessToday.In
New Delhi, September 18, 2020
Russian COVID-19 vaccine, 'Sputnik-V' which has been launched in Russia, may soon become the first official vaccine to be launched in India if clearances are granted. For this, GV Prasad-led Dr Reddy's Laboratories has signed a pact with Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) to manufacture around 10 crore vaccines in India. Both have been planning to roll out the vaccine in India as early as November. RDIF CEO Kirill Dmitriev spoke to India Today TV about the plans for the launch of vaccine in India. Watch this exclusive interview to know more.Also Read: Russian coronavirus vaccine: 1 in 7 volunteers report side-effects


PAGES 1 OF 7  12345